Table 2.

Treatment Management and Follow up.

Characteristic	Group 1 (Limited tissue on excision)	Group 2 (Primary surgery vs neoadjuvant therapy)			Group 3 (Neoadjuvant chemoendocrine vs endocrine)			P value
Oncotype RS group on CNB		L	I	H	L	I	H
Neoadjuvant therapy								0.33
Yes
Endocrine	1	1	11	1	16	3	2
Chemo-endocrine	0	0	0	0	5	3	4
No (primary surgery only)	5	14	6	3	0	0	0
Surgery type								0.80
Breast conserving surgery	4	11	7	1	5	5	3
Total mastectomy	2	3	9	3	13	0	2
Pathologic stage on resection								>0.05
pT1	6	10	4	2	6	1	3
pT2	0	3	7	2	7	2	2
pT3	0	0	3	0	5	2	0
pT4	0	1	0	0	0	0	0
Pathologic nodal status
N0	6	8	7	2	6	2	4
N1-2	0	6	7	2	12	3	1
Adjuvant therapy								>0.05
Endocrine	5	11	8	0	13	1	4
Chemotherapy	1	3	6	4	4	4	1
Recurrence	0	0	0	1	1	1	0	0.38
Mean follow up (months)	36	33			28